225Aс/213Bi generator for direct synthesis of 213Bi-labeled bioconjugates
{{output}}
Background: 213Bi is a short-lived radionuclide currently trialed for alpha therapy of various oncological diseases. A serious obstacle to the wide medical use is decay losses of 213Bi during a conventional synthesis of radiophar... ...
